StonvexLoading…
StonvexStonvexStonvexCore line items from BSM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $422.33M | $439.43M | $501.10M | $784.28M |
Operating Income | $308.40M | $273.11M | $423.60M | $482.50M |
Net Income | $299.93M | $271.33M | $422.55M | $476.48M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $1.34B | $1.22B | $1.27B | $1.27B |
Total Liabilities | $207.10M | $89.47M | $49.54M | $61.27M |
Cash & Equivalents | $1.48M | $2.52M | $70.28M | $4.31M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | Not available | Not available | Not available |